Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Caulfield

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
European Heart Journal|January 11, 2013
Genes for blood pressure: an opportunity to understand hypertensionGeorg B Ehret, Mark J Caulfield
Iscience|October 9, 2023
Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohortEmma F Magavern, , Damian Smedley, et al.
Current Opinion in Nephrology and Hypertension|January 28, 2026
New pharmacological therapies for hypertensionManish Saxena, Feng J He, Mark J Caulfield
Circulation Research|May 11, 2013
Advances in blood pressure genomicsPatricia B Munroe, Michael R Barnes, Mark J Caulfield
Annals of Translational Medicine|September 14, 2018
Hypertension genomics and cardiovascular preventionFu Liang Ng, Helen R Warren, Mark J Caulfield
Methods in Molecular Medicine|July 21, 2005
Selection of candidate genes in hypertensionCharles A Mein, Mark J Caulfield, Patricia B Munroe
Genome Research|September 27, 2007
Information capture using SNPs from HapMap and whole-genome chips differs in a sample of inflammatory and cardiovascular gene-centric regions from genome-wide estimatesChris Wallace, Richard J Dobson, Patricia B Munroe, et al.
Human Molecular Genetics|February 7, 2004
Genetics of essential hypertensionCharles A Mein, Mark J Caulfield, Richard J Dobson, et al.
British Journal of Clinical Pharmacology|May 5, 2023
CYP2C19 loss-of-function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British-South Asian cohortEmma F Magavern, David A van Heel, , et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2024
Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension TherapyEmma F Magavern, Vikas Kapil, Manish Saxena, et al.
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
European Heart Journal|January 11, 2013
Genes for blood pressure: an opportunity to understand hypertensionGeorg B Ehret, Mark J Caulfield
Iscience|October 9, 2023
Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohortEmma F Magavern, , Damian Smedley, et al.
Current Opinion in Nephrology and Hypertension|January 28, 2026
New pharmacological therapies for hypertensionManish Saxena, Feng J He, Mark J Caulfield
Circulation Research|May 11, 2013
Advances in blood pressure genomicsPatricia B Munroe, Michael R Barnes, Mark J Caulfield
Annals of Translational Medicine|September 14, 2018
Hypertension genomics and cardiovascular preventionFu Liang Ng, Helen R Warren, Mark J Caulfield
Methods in Molecular Medicine|July 21, 2005
Selection of candidate genes in hypertensionCharles A Mein, Mark J Caulfield, Patricia B Munroe
Genome Research|September 27, 2007
Information capture using SNPs from HapMap and whole-genome chips differs in a sample of inflammatory and cardiovascular gene-centric regions from genome-wide estimatesChris Wallace, Richard J Dobson, Patricia B Munroe, et al.
Human Molecular Genetics|February 7, 2004
Genetics of essential hypertensionCharles A Mein, Mark J Caulfield, Richard J Dobson, et al.
British Journal of Clinical Pharmacology|May 5, 2023
CYP2C19 loss-of-function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British-South Asian cohortEmma F Magavern, David A van Heel, , et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2024
Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension TherapyEmma F Magavern, Vikas Kapil, Manish Saxena, et al.
Pageof 17